Since the origins of DNA-based life, the enzyme ribonucleotide reductase (RNR) has spurred proliferation because of its ratelimiting role in de novo deoxynucleoside-triphosphate (dNTP) biosynthesis. Paradoxically, the large subunit, RNR-α , of this obligatory two-component complex in mammals plays a context-specific antiproliferative role. There is little explanation for this dichotomy. Here, we show that RNR-α has a previously unrecognized DNA-replication inhibition function, leading to growth retardation. This underappreciated biological activity functions in the nucleus, where RNR-α interacts with ZRANB3. This process suppresses ZRANB3's function in unstressed cells, which we show to promote DNA synthesis. This nonreductase function of RNR-α is promoted by RNR-α hexamerization-induced by a natural and synthetic nucleotide of dA/ClF/CLA/FLU-which elicits rapid RNR-α nuclear import. The newly discovered nuclear signaling axis is a primary defense against elevated or imbalanced dNTP pools that can exert mutagenic effects irrespective of the cell cycle.
R
eplication fidelity is paramount for fitness 1 . One factor controlling fidelity of DNA replication is an optimal dNTP pool concentration, which ensures high-fidelity nucleotide incorporation and proofreading. The enzyme ribonucleotide reductase (RNR) stands at the epicenter of dNTP pool maintenance. RNR is rate limiting for dNTP production 2 and catalyzes the reduction of CDP, ADP, GDP and UDP to deoxynucleotides, providing dNTPs for DNA synthesis and repair. RNR senses both the absolute levels and relative ratios of NTPs/dNTPs, altering its reductase activity and/ or NDP-substrate preference to balance dNTP pools and promote high-fidelity replication. Mammalian RNR requires two subunits-α and β -for reductase activity. The minimal quaternary state of active reductase is α 2 β 2 (ref. 3 ). However, modulation in reductase activity brought about by nucleotide-pool changes is coupled to modifications in RNR quaternary structure. dATP-the universal allosteric downregulator of RNR-induces α -subunit-specific hexamerization independent of RNR-β . The dATP-driven formation of 'reduced reductase activity' hexameric states (α 6 ) is a regulatory mechanism conserved across eukaryotic RNR-α (refs [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] ). Conversely, the positive allosteric stimulator ATP can induce distinct 'reductase active' α 6 states 3 . α 6 RD and α 6 RS denote dATP-promoted 'reductase activity downregulated' RNR-α hexamers and ATP-promoted 'reductase activity stimulated' RNR-α -hexamers, respectively.
RNR-α protein is constitutively present because of its long halflife, whereas RNR-β protein (t 1/2 ~ 3 h) 3 peaks in S-phase. Another constitutive, low-expression RNR-β isoform, p53β , supplies dNTPs outside S-phase in conjunction with RNR-α (ref. 3 ). All RNR isoforms are predominantly cytosolic 3, 14, 15 . Although RNR activity is elevated in some cancer cells, RNR-α -subunit-specific expression in cancer can be either elevated or downregulated relative to normal tissue 3, [16] [17] [18] . As ribonucleotide reduction is an essential metabolic function that sustains rapid cancer growth 19 , RNR is the target of several anticancer drugs. Although overexpression of RNR subunits confers resistance to RNR-targeting drugs and DNA-damaging chemotherapeutics 3 , effects of the RNR-α subunit are context and stage specific 3 . RNR-α lies in a chromosomal region frequently lost during oncogenesis 20 ; RNR-α overexpression alone suppresses oncogenic ras-induced transformation in cells and mice xenografts 21 and promotes survival post-therapy 3, [21] [22] [23] [24] [25] [26] [27] [28] , whereas RNR-α knockdown promotes oncogenic ras-induced transformation 22 . These findings combined with RNR-α 's status as an essential gene indicate that RNR-α is likely a haploinsufficient tumor-suppressor gene 29 . The mechanism, however, is unknown. Nevertheless, because RNR-α knockdown is tumor promoting, these activities likely do not stem from RNR enzymatic function 3 .
Here we offer the first molecular basis of RNR-α -alone-promoted growth-suppression. This activity is selectively associated with nuclear RNR-α directly interacting with ZRANB3 (zinc-finger-RAN-binding-domain-containing-3), which impedes ZRANB3− PCNA complexation that we find promotes DNA synthesis in nonstressed cells. We identify both small-molecule (natural nucleotide-dATP and antileukemic nucleotide drugs) and protein (IRBIT and importin-α ) modulators of this novel nuclear signaling axis, which we show is independent of RNR reductase activity but dependent on RNR-α hexamerization.
Results

ZRANB3 is a domain-specific direct binder of RNR-α.
We undertook a large-scale yeast two-hybrid (Y2H) screen using the Gal4-DNA-binding domain fused to full-length RNR-α (Fig. 1a) . The ZRANB3 C terminus (residues 929-1079) emerged as an RNR-α -specific interactor ( Fig. 1a; Supplementary Fig. 1a ), in addition to the known binder of RNR-α , namely, RNR-β (residues-279-389, a known RNR-α -binding site).
ZRANB3 is a replication-associated SNF2 protein and ATP-driven DNA-rewinding motor [30] [31] [32] that also possesses ATP-hydrolysiscoupled endonuclease activity and annealing activity. ZRANB3 associates with PCNA through two functionally coupled motifs 30, 32 , the PIP (PCNA-interacting-protein) box (residues 519-526) and the APIM (AlkB-homolog-2-PCNA-interaction) motif (residues 1074-1078) ( Supplementary Fig. 1a ). ZRANB3 and PCNA colocalize in unstressed cells at discrete nuclear foci termed replication factories 30, 31 . The role of this complex in nonstressed cells is unknown. However, after DNA damage [30] [31] [32] , ZRANB3 cooperates with ubiquitinated PCNA to facilitate replicative bypass, repair, and sister-chromatid exchange at DNA lesions-a process typified by formation of small ZRANB3-PCNA foci.
We verified the ZRANB3-RNR-α interaction in nonchallenged cells by co-immunoprecipitation (co-IP) in HEK293T cells. The interaction required ZRANB3′ s C terminus; specifically, the HNH domain and the APIM motif ( Fig. 1b; Supplementary Fig. 1b,c) . Recombinantly purified C-terminal domains of ZRANB3 (residues 929-1079, HNH-domain and APIM-motif) directly bind to full-length recombinant RNR-α in vitro ( Supplementary Fig.  1d ). ZRANB3-RNR-α interaction requires neither the PIP box nor the polyubiquitin-chain recognition function of ZRANB3 ( Supplementary Fig. 1b-e) . The ZRANB3-RNR-α interaction is also independent of helicase or nuclease activity of ZRANB3 ( Supplementary Fig. 1e ). 
NLS-RNR-α constructs function similarly to untagged RNR-α.
Consistent with results from previous studies [30] [31] [32] , ZRANB3 localizes to the nucleus (Fig. 1c) . RNR-α is primarily cytosolic 3, 14, 15 . We first investigated how these two proteins meet in cells. All previous reports on RNR-α nuclear translocation 3 are linked to RNRreductase activity and DNA damage either in stressed/damaged cells or upon prolonged treatment with cytotoxic nucleoside antimetabolites.
We generated nuclear-targeted RNR-α constructs, both wild type (wt) and C429S (a reductase-inactive mutant) 33 . The expression levels/stabilities of these nuclear localization signal (NLS)-tagged variants is similar to non-NLS-tagged equivalents in HeLa and HEK293T cells ( Supplementary Fig. 2a-c) . RNR-β levels and localization showed no change. We also investigated how dATP feedback inhibition, one of the many nuanced aspects of RNR-α regulation, which may be influenced by RNR-α -overexpression, was involved in this process. We thus examined NLS-tagged and nontagged variants of RNR-α (D57N), which lacks dATP-feedback regulation but features similar specific reductase activity to that of wt-RNR-α (refs 3, 5, 6 ). The ZRANB3 interaction was maintained with the D57N mutant in lysates ( Supplementary Fig. 2d ). All three NLStagged variants-wt, C429S, and D57N-were nuclear localized ( Supplementary Fig. 2a ). Non-NLS-tagged RNR-α (wt/D57N) was primarily cytosolic 8, 14, 15 . Because endogenous RNR-β is primarily cytosol localized 3,14,15 , we predicted that overexpression of nuclear-specific-RNR-α would not contribute to the amount of reductase-active RNR complex and would not affect dNTP pools. Overexpression of nucleartargeted RNR-α ( Supplementary Fig. 2a ) did not perturb dNTP pools, but that of non-NLS-tagged-RNR-α (mostly cytosolic) ( Supplementary Fig. 2a-c ) elevated dATP levels ( Supplementary  Fig. 2e ). Thus, nuclear-restricted constructs do not perturb canonical RNR function.
RNR-α impedes ZRANB3-PCNA binding in unstressed cells.
Deletion of the ZRANB3 APIM motif leads to 95% reduction in PCNA-mediated recruitment of ZRANB3 to DNA-damage sites 30 . Because the APIM motif is required for the ZRANB3-RNR-α interaction ( Fig. 1b; Supplementary Fig. 1c,d ), we proposed a 'competition model' wherein nuclear RNR-α forms a complex with ZRANB3 inside the nucleus, preventing the ZRANB3-PCNA interaction in the absence of DNA damage. Evidence is as follows: (1) overexpression of either reductase-dead(C429S)-or wt-RNR-α -NLS reduced ZRANB3-PCNA association in co-IP ( Fig. 1d; Supplementary Fig.  3a ,b). (2) Using purified proteins, the ZRANB3(HNH-APIM)-RNR-α direct interaction was reduced in the presence of excess PCNA in the binding buffer ( Supplementary Fig. 3c ). (3) Excess PCNA fully eluted recombinant RNR-α prebound to ZRANB3(HNH-APIM)-coated anti-HA beads ( Supplementary Fig. 3d ) within 30 min. (4) On a similar time scale, recombinant PCNA interrupted co-IP of full-length ZRANB3 and RNR-α (Fig. 1e) . (5) ZRANB3 and nuclear RNR-α partly colocalized independently of reductase activity ( Fig.  1c; Supplementary Fig. 4a,b) . Consistent with the mutually exclusive binding of RNR-α and PCNA to ZRANB3, RNR-α -NLS overexpression reduced ZRANB3-PCNA puncta colocalization in both transient expression lines ( Fig. 1c; Supplementary Fig. 4b ) and stably integrated lines ( Supplementary Fig. 4c,d ).
Elevated nuclear RNR-α did not affect nonhomologous end joining ( Supplementary Fig. 5a ), nor did it increase DNA damage in the basal state or upon mitomycin-C treatment in both transiently transfected cells and tetracycline-inducible Flp-In isogenic lines ( Supplementary Fig. 5b,c) . PCNA ubiquitination-an established DNA-damage-induced signaling mechanism-was also unaffected (Supplementary Fig. 5d ) 30, 34 . Therefore, this novel nuclear RNR-α -ZRANB3 interaction is uncoupled from the classical role of ZRANB3 in DNA-damage-induced replication stress.
In both native and cross-linked iPOND experiments, which identify proteins on nascent DNA 35 , RNR-α was not associated with chromatin ( Supplementary Fig. 5e ) and did not colocalize with PCNA/BrdU puncta ( Supplementary Fig. 6 ), further indicating that nuclear RNR-α is not recruited to sites of DNA synthesis.
As previously reported, ZRANB3 was recruited to small PCNA foci upon mitomycin-C treatment, in the backdrop of either primarily cytosol-localized RNR-α (D57N) or nuclear-targeted reductasedead-RNR-α -NLS(C429S) ( Supplementary Fig. 4a,b) . These small PCNA-ZRANB3 foci did not contain RNR-α , consistent with the competition model between RNR-α and PCNA and with the damage and nondamage roles of PCNA, ZRANB3, and RNR-α being uncoupled. Thus, RNR-α -ZRANB3-PCNA forms a novel axis wherein the degree of ZRANB3 association with PCNA is modulated by RNR-α -nuclear levels. Upon DNA damage, ZRANB3 reassociates with PCNA to aid DNA damage tolerance.
Nuclear RNR-α elicits growth inhibition. Because nuclear-targeted RNR-α affected the constitutive interaction between ZRANB3 and PCNA, we hypothesized that nuclear RNR-α may regulate proliferation by affecting DNA synthesis. RNR-α overexpression suppresses the growth of human colon carcinoma cell line (Colo320-HRS) 21 .
Various nuclear-localized RNR-α constructs-RNR-α -NLS, RNR-α (C429S)-NLS, and RNR-α (D57N)-NLS-were thus made and validated against primarily cytosol-localized variants, RNR-α (D57N), and RNR-α -NES ( Supplementary Fig. 2a-c) . Consistent with our hypothesis, BrdU-incorporation analysis, reporting on DNA synthesis (S-phase cells) 36 , demonstrated that cells overexpressing nuclear-localized RNR-α showed reduced DNA synthesis relative to cells in the same plate not expressing the transgene or expressing the cytosolic hypomorphic variant RNR-α (D57N) ( Supplementary  Fig. 7 ). These data from three different cell lines (HeLa, Cos-7, and HEK293T) showed that it is the presence of nuclear RNR-α rather than nuanced differences between each mutant that is responsible for downregulation of DNA synthesis. The isotypic output from RNR-α and RNR-α -NLS variants (regardless of reductase activity), all of which have a significant nuclear contribution, provided a first hint that saturation of a specific binding site has occurred (Supplementary Fig. 8 ).
Nuclear-RNR-α suppresses growth in primary cells. Homozygous knock-in of the RNR-α (D57N) mutation in the mouse RNR-α gene (Rrm1) causes embryonic lethality, but early embryos could be used to derive mouse embryonic fibroblasts (MEFs). MEFs from homozygous Rrm1 +/+ or Rrm1 D57N/D57N embryos 10 d postfertilization were cultured for 10 more days. BrdU incorporation analysis suggested that Rrm1 D57N/D57N MEFs were more proliferative than Rrm1 +/+ cells ( Fig. 2a; Supplementary Fig. 9 ). Notably, RNR-α (D57N) was excluded from the nucleus, in contrast to wt RNR-α , explaining these differences.
ZRANB3 is a positive regulator of DNA synthesis. Given the involvement of PCNA in our newly identified nuclear RNR-α -ZRANB3 axis, we investigated the consequences on DNA synthesis. We used EdU/BrdU dual-pulse labeling to accurately monitor global DNA synthesis occurring over a precise time in S-phase (Fig. 2b, top) . RNR-α overexpression, which increases nuclear RNR-α levels, reduced DNA-synthesis rates (Fig. 2c) . Ectopic ZRANB3 overexpression partially rescued this nuclear RNR-α -promoted DNA-synthesis suppression (Fig. 2c) .
These data allowed us to propose three possible models by which nuclear RNR-α suppresses growth through a mechanism involving inhibition of DNA synthesis. Model A: the nuclear RNR-α -ZRANB3 complex suppresses DNA synthesis through ZRANB3 gain of function. Model B: nuclear RNR-α induces loss of function of ZRANB3; i.e., ZRANB3 is a novel promoter of DNA synthesis.
Model C: nuclear RNR-α -ZRANB3 interaction has no correlation with growth suppression.
Cells deficient for ZRANB3 (~70% knockdown efficiency, Supplementary Fig. 10a ) exhibited ~30% decrease in the rate of DNA synthesis by both fiber spreading and fiber combing (Fig. 2b,d , middle/bottom and bars 1-2, respectively; Supplementary  Fig. 10b-e) . EdU/BrdU dual-pulse labeling (Fig. 2b, top ) also revealed 30-40% suppression of BrdU incorporation (second pulse) upon ZRANB3 siRNA knockdown in HEK293T cells ( Supplementary  Fig. 10f ). Identical analyses in tetracycline-inducible short hairpin RNA (shRNA) knockdown in HeLa cells as well as constitutive expression of shZRANB3 in NIH-3T3 cells showed moderate suppression of DNA synthesis (~25% in BrdU-incorporation in HeLa, and 28% and 14% in EdU-and BrdU-incorporation, respectively, in NIH-3T3) ( Supplementary Fig. 11a,b) . ZRANB3 overexpression rescued the suppression (Fig. 2e, left (HEK293T) ; Supplementary Fig. 11c (HeLa) ). Broadly consistent with a mechanism involving PCNA, both PIP-and APIM-deleted ZRANB3 ( Supplementary Fig. 1a) could not rescue ZRANB3 knockdown ( Fig. 2e, right; Supplementary Fig. 11c) . A PIP-inactivation mutation (Q519A, Supplementary Fig. 1e ) did not rescue DNA synthesis (Fig. 2e, right) . A nuclease-dead mutant (H1021A, Supplementary  Fig. 1e ) rescued ZRANB3 knockdown (Fig. 2e, right) , further indicating that this newly identified role of ZRANB3 is distinct from its canonical role in DNA damage [30] [31] [32] . Notably, ZRANB3 depletion neither altered the nuclear:cytosol distribution of RNR-α (or RNR-β ) ( Supplementary Fig. 12a ) nor changed γ -H2AX-levels (either in untreated or mitomycin-C-treated cells relative to controls (Supplementary Fig. 12b ). However, ZRANB3 knockdown reduced proliferation rate and caused an increase in G1 (Supplementary Fig. 13 ). LDH release assays indicated no cell death (Supplementary Fig. 14 ; NIH-3T3, HEK293T, and HeLa cells).
Overexpression of RNR-α (D57N) (nuclear-excluded variant, Supplementary Fig. 2a-c) did not suppress DNA synthesis ( Fig. 2f ; Supplementary Fig. 15a ), whereas overexpression of wt-RNR-α , RNR-α -NLS, and the reductase-dead-RNR-α -NLS(C429S) exerted an equal extent of DNA-synthesis suppression ( Supplementary  Fig. 15a,b) . The similarity in the extent of suppression between wt-RNR-α and two NLS-tagged variants, namely wt-RNR-α -NLS and C429S (both enriched > 10-fold in the nucleus compared to wt-RNR-α ; Supplementary Fig. 2a ), reinforces that saturation of a specific binding site-later identified as ZRANB3-occurs in the nucleus (Supplementary Fig. 8 ). As shown above, these data are not a function of dNTP pool changes upon RNR-α overexpression ( Supplementary Fig. 2e ).
These findings indicate a novel role for ZRANB3 in nonstressed cells; ZRANB3 is a positive regulator of DNA synthesis and cell proliferation, and nuclear RNR-α inhibits this function, supporting model B (Supplementary Fig. 15c ). Consistent with this, an increase in nuclear RNR-α independent of reductase activity, via either wt-RNR-α overexpression or expression of nuclear-restricted construct, suppressed proliferation ( Supplementary Fig. 15d, top) . Interestingly, overexpression of RNR-α , regardless of reductase activity, increased the proportion of cells with S-phase DNA content relative to the D57N analog ( Supplementary Fig. 15d , bottom). EdU staining, however, showed a reduced proportion of cells actively synthesizing DNA (Supplementary Fig. 15e ). These outcomes observed in isogenic tetracycline-inducible HeLa cells replicated those Supplementary Fig. 9 . b, Schematics for dual-pulse labeling, single-DNA fiber staining, and single-DNA fiber combing. For single-DNA fiber combing, 3× wash cycles were performed after IdU treatment (see Methods). c, Overexpression of wt ZRANB3 partially rescues nuclear RNR-α -induced DNA synthesis suppression. The normalized DNA synthesis efficiency (reported by "normalized BrdU-incorporation efficiency") was determined by sequential dual-pulse labeling using EdU/BrdU in tetracycline-inducible isogenic cells expressing wt-RNR-α -NLS compared to the nuclear-translocation-defective hypomorph RNR-α (D57N). These cells were also transfected with either empty vector or a vector encoding wt-ZRANB3. Data for cells transfected with either empty or ZRANB3 plasmid are respectively divided by the mean of the RNR-α (D57N) cells transfected with either empty or ZRANB3 plasmid. Data show mean ± s.e.m. (RNR-α (D57N), n = 558; RNR-α -NLS, n = 376; RNR-α (D57N), ZRANB3, n = 368; RNR-α -NLS, ZRANB3, n = 397). Also see Fig. 7 ). No detectable cell death occurred ( Supplementary Fig. 15f ).
Nuclear-RNR-α inhibits ZRANB3-supported DNA synthesis. To further substantiate Model B ( Supplementary Fig. 15c ), we showed by fiber-staining analysis that DNA-synthesis suppression upon tetracycline-induced RNR-α -NLS overexpression (Fig. 2d , bars 3-4) did not occur in ZRANB3-deficient cells. This result confirms that nuclear RNR-α -promoted DNA synthesis suppression is ZRANB3 dependent. A dual-pulse-labeling method confirmed that the effect is independent of reductase activity ( Supplementary Fig. 16a,b) .
PCNA overexpression alone did not cause lengthening of tracks in nuclear-excluded hypomorph-RNR-α (D57N)-expressing cells. However, dual overexpression of RNR-α -NLS and PCNA increased DNA fiber lengths relative to RNR-α -NLS alone ( Supplementary   Fig. 16c ), reinforcing the competition between PCNA and nuclear-RNR-α for ZRANB3.
Sequential EdU/BrdU dual-pulse labeling in HeLa cells showed that BrdU incorporation (second pulse) was significantly lower in cells expressing RNR-α -NLS relative to the hypomorphic mutant RNR-α (D57N) ( Supplementary Fig. 16d ). PCNA overexpression fully rescued this effect ( Supplementary Fig. 16d ).
A non-RNR-α-binding ZRANB3 rescues reduced replication.
There is significant variation across known APIM domains 37 , and there is some variation in ZRANB3-APIM domains across species ( Supplementary Fig. 17a ). We thus mutagenized various residues within and around the APIM domain (1074-1078) in an attempt to derive a ZRANB3 mutant that could not bind RNR-α but that would retain PCNA binding. From 13 mutants, we identified two potential ZRANB3 mutants not able to bind RNR-α as well as Fig. 17b ). We screened these mutants for the ability to rescue RNR-α -overexpression-induced DNA synthesis suppression. Using low levels of ZRANB3 plasmid in which rescue by wt-ZRANB3 was measurable but minimal, we showed that the V1077A mutant rescued (to a significantly larger extent than wt-ZRANB3) the DNA synthesis suppression promoted by wt-RNR-α or RNR-α -NLS overexpression ( Supplementary Fig. 17c ). We validated that V1077A is functional for basal ZRANB3 activity: V1077A overexpression in cells transfected with siZRANB3 rescued DNA synthesis ( Supplementary Fig. 17d ). Critically, an analogous APIM motif-KFLAR (bolded residue is analogous to ZRANB3-V1077A)-is found in RAD51B, which is known to interact with PCNA via this conserved APIM motif 37 .
dATP-mimetic drugs cause rapid RNR-α translocation. The D57N mutant was the only RNR-α variant hypomorphic for growth suppression. Because this mutant is unable to be regulated by dATP, we proposed that dATP elevation might govern this axis. We first investigated the effects of non-natural deoxyadenosine (dA) mimics on the newly discovered nuclear role of endogenous RNR-α . In three different cells (HeLa, Cos7, and HEK293T), treatment with clinically used antileukemic dA-mimetics (clofarabine (ClF), cladribine (CLA), and fludarabine monophosphate (FLUMP)) under conditions that drive RNR-α 6 RD resulted in nuclear trans location of a small amount of RNR-α ( Fig. 3a-c ; Supplementary Fig. 18a-g ). Identical outcomes were obtained by both immunofluorescence and nucleus/cytosol fractionation in blood cancer lines (K562, Raji(BL) and OCI-LY3(ABC-DLBCL)) treated with ClF (at a lower (
shControl shRNR-β shRNR-β shControl dose; Fig. 3b,c; Supplementary Fig. 18h,i) . The similar response across numerous lines indicates a general phenomenon.
As (i) the volume of the nucleus is small compared to that of the cytosol 38 , (ii) the basal amount of nuclear-RNR-α is low, and (iii) the percentage RNR-α translocation upon treatment with dA mimetics was modest, cytosolic RNR-α levels were unaltered during nuclear translocation. Consistent with previous reports 8, 10 , expression of each RNR subunit was unaltered by ClF ( Supplementary Fig. 19a ). RNR-β /p53β localization was unchanged ( Fig. 3a; Supplementary  Fig. 18a ). Although immunofluorescence experiments can be affected by focal plane misalignments, selective translocation of RNR-α over RNR-β rules this artifact out. Ectopic RNR-β /-p53β -binding-defective loss-of-function mutant RNR-α (W684G) 39 translocated as efficiently as RNR-α ( Supplementary Fig. 19b ). The EC 50 for translocation of endogenous RNR-α was < 300 nM at 3 h, and within 30 min of treatment translocation reached saturation with a nuclear RNR-α content ~5-fold above background (Fig. 3b,c ; Supplementary Fig. 19c-e) . This rapid timeframe means that translocation is unlikely to be caused by cell-cycle perturbation, apoptosis, or cytotoxicity, which we also confirmed to occur more slowly. We found no change in RNR-α nucleus:cytosol distribution between S-phase and outside of S-phase. Thus, RNR-α nucleus:cytosol partitioning is unchanged across the cell cycle ( Supplementary Fig. 20a,b) .
Neither gemcitabine (F2C), an RNR-α -binding inactivator 3 , nor triapine (3AP), a RNR-β -isoform-specific inhibitor 40 , caused RNR-α nuclear translocation ( Supplementary Fig. 20c ). ClF elicited RNR-α translocation in RNR-β /-p53β -knockdown lines ( Fig. 3d;  Supplementary Fig. 20d ). Although these regimens change dNTP pool levels 41 , as we subsequently show, dA and ClF treatment did not affect dNTP pools similarly, implying that this nuclear signaling is not tuned to specific nucleotide changes.
A histone acetyl transferase, Tip60, mediates RNR-α -specific nuclear translocation upon DNA damage 42, 43 . However, Tip60-binding-defective mutant-RNR-α (Δ C) 42 -still translocated (Fig. 3e) . No DNA damage occurred post ClF treatment based on the number Images show class averages representing the multiple conformations adopted by these oligomers. For each nucleotide, a data set of ~2,000 particle images was collected and subjected to a maximum-likelihood classification approach, assuming the existence of ten classes. RNR-α 6 RD hexamers were assembled in the presence of the indicated nucleotide. In the dilution step before preparing the grids, the nucleotide was not included (see Methods of γ -H2AX foci ( Supplementary Fig. 20e ). Taken altogether, these results show that this mode of RNR-α nuclear translocation is independent of DNA damage.
ClF drives endogenous RNR-α-ZRANB3 association.
The low expression levels of RNR-α and ZRANB3 render the study of their endogenous interactions challenging 8, 31 . Nevertheless, we successfully co-IPed endogenous ZRANB3 and endogenous RNR-α from lysates of native HEK293T cells ( Supplementary  Fig. 21a ). No IP was observed when using an isotype antibody control. ClF treatment had no effect on the observed association in lysates because nucleus/cytosol-compartmentalization is lost (Supplementary Fig. 21b ).
To investigate compartmentalized association, we deployed a cross-linking assay. HEK293T cells pretreated with either siControl or siZRANB3 were treated with ClF or DMSO for 3 h and then treated with a cell-permeable cross-linker, EGS (ethylene glycol bis(succinimidyl succinate)), for 1 h. Following washing in quenching buffer, lysis, and IP with anti-RNR-α , western blotting with anti-ZRANB3 antibody showed that high-molecular-weight (HMW) ZRANB3-RNR-α complexes were observed only in ClFtreated siControl cells (Supplementary Fig. 21c ). These HMW bands were significantly reduced in ZRANB3 knockdown cells. One of the HMW cross-linked bands was consistent with a crosslinked heterodimeric RNR-α -ZRANB3 complex, further indicating a direct interaction. The other bands are likely RNR-α tetramer/ hexamer complexed to ZRANB3. Similar overall outcomes were observed upon replicating the cross-linking analyses similarly in HeLa (Supplementary Fig. 21d ). Here, isotype IgG was used instead of siRNA.
Antileukemic drugs induce discrete RNR(α6 RD ) hexamers.
Electron micrographs of negatively stained recombinant RNR-α treated with CLA/FLU-nucleotides revealed α -hexamers (α 6 RD ) ((RNR-α ) 6 CLATP /(RNR-α ) 6 FLUTP ; Fig. 4a; Supplementary Fig. 22 ; Supplementary Table 1) similar to those formed upon ClF treatment 8 . Consistent with our previous studies 10 , the hexamers (α 6 RD ) formed by the different drugs were pleomorphic ( Fig. 4a;  Supplementary Fig. 22 ) despite sharing a common 'trimer-ofdimers' architecture ( Supplementary Fig. 23 ). It is likely that (a) certain hexameric (α 6 RD ) state(s) distinct from the ATP-induced α 6 RS state ((RNR-α ) 6 ATP ) initiate(s) nuclear translocation. In line with the cell-based data for the nuclear-excluded hypomorph, the enzymatically active but α -hexamerization (α 6 RD )-defective RNR-α (D57N)mutant 3,5,6 did not translocate upon ClF treatment ( Fig. 4b;  Supplementary Fig. 20f ). Because RNR-α (D57N) likely cannot form hexamers (α 6 RD ), the (RNR-α ) 6 dATP (or similar) state is probably necessary for translocation.
dA, an α 6 RD -inducing allosteric-suppressor 3 , elicited RNR-α -specific translocation; adenosine (A) and deoxyguanosine (dG) did not ( Supplementary Figs. 24 and 25a,b) . dA-induced translocation was equally effective when dA, dT, dG, and dC were added together ( Supplementary Fig. 25c ), indicating that translocation is independent of other nucleotides (nonhexamer-α 6 RD inducers). RNR-α hexamerization α 6 RD induced partial nuclear import functions independently of ZRANB3 (Supplementary Fig. 26 ).
RNR-α nuclear translocation is rapidly reversible. RNR-α associated with importin-α in a ClF-nucleotide-induced manner ( Fig. 4c;  Supplementary Fig. 27 ), explaining the elevated nuclear component upon hexamer (α 6 RD ) formation. Although dA nucleotides only weakly influenced association of importin with RNR-α , (α 6 RD ) dATP are much less kinetically stable than (α 6 RD ) ClFTP3 (ref. Removal of dA from cells that had undergone dA-induced RNR-α -translocation elicited complete retrotranslocation ( Fig. 4d;  Supplementary Fig. 28a ) within 3-4 half-lives of dATP in asynchronous cells 44 . Whereas treatment of cells with dA significantly reduced DNA synthesis within 30 min ( Supplementary Fig. 28b , siControls-c(bar:1-2)), dA removal restored DNA-synthesis within 30 min (Supplementary Fig. 28c )-the same time scale as dAremoval-driven RNR-α retrotranslocation ( Fig. 4d; Supplementary  Fig. 28a ) and the time it takes for RNR-α to elute from the RNR-α -ZRANB3 complex in vitro (Fig. 1e, Supplementary Fig. 3d ). Thus, RNR-α translocation/retrotranslocation is kinetically competent to both stall DNA synthesis transiently upon elevated dATP and allow restart once dATP-levels are rebalanced.
Nuclear-RNR-α signaling is not due to dNTP-pool changes.
Addition of dA did not perturb dTTP pools ( Supplementary  Fig. 28d,e) . Thus, reduced BrdU incorporation upon dA-treatment is not due to increased competition between dTTP and (BrdU)TP for DNA incorporation. Although dA treatment raises dATP levels but lowers dCTP and dGTP levels, addition of dNs (i.e., dA, dG, dC, and dT) elevates all dNTP levels except dGTP (Supplementary Fig. 28f ). Both of these conditions cause RNR-α translocation ( Supplementary  Figs. 24 and 25 ) as well as ZRANB3-dependent DNA synthesis inhibition in the dual-pulse assay (Supplementary Fig. 28g ). dT was omitted from the dual-pulse assay ( Supplementary Fig. 28g ), as it competitively inhibits BrdU incorporation (see Supplementary  Fig. 28e for dNTP-pools upon dA/dG/dC-treatment).
Contrary to dA addition, which raised dATP and lowered dCTP and dGTP, ClF treatment had little effect on dCTP pools but lowered both dATP and dGTP ( Supplementary Fig. 28f ). Because both dA-and ClF-elicited hexamers (α 6 RD ) translocate to the nucleus but ClF perturbs dNTP pools differently than dA or dA/dG/dC/(dT) ( Supplementary Fig. 28e,f) , dNTP-pool changes are not strongly correlated with RNR-α translocation.
IRBIT negatively regulates RNR-α nuclear translocation.
Although the preeminence of dATP controlling this pathway may be surprising, cells exclusively use dATP to regulate global dNTP synthesis (and balance dNTP pools). Furthermore, the only current candidate for mammalian analogs of the lower eukaryote RNRreductase-activity regulators (Sml1/Spd1) is IRBIT 45 , a dATP-controlled, hexamer (α 6 RD )-specific regulator.
IRBIT, a cytosolic protein involved in calcium signaling, negatively regulates RNR-reductase activity by selectively binding (α 6 RD ) dATP45 . We hypothesized that IRBIT is a negative regulator of RNR-α nuclear translocation by sequestering (α 6 RD ) dATP . IRBIT overexpression antagonized ClF-induced RNR-α translocation ( Fig. 5a ; Supplementary Fig. 29a ), consistent with previous reports that IRBIT binds selectively to (α 6 RD ) dATP45 . IRBIT phosphorylation was unchanged by ClF ( Supplementary Fig. 29b ). Thus, ClF did not modulate the phosphorylation-dependent IRBIT-RNR-α interaction 45 . Basal nuclear RNR-α levels were increased by IRBIT knockdown in K562, HeLa and Raji cells ( Supplementary Fig. 30a-d ) but had little effect on cell-cycle distribution (Supplementary Fig. 30e ). In IRBIT knockdown HeLa cells, IRBIT overexpression reduced RNR-α nuclear fraction (Supplementary Fig. 31a ). Currently, the preponderance of data indicate that ATP-induced active hexamers also form 3, 7 . Lower panel, this work uncovers a novel oligomerization-dependent reductase-activityindependent moonlighting function of RNR-α . This function-negative-regulation of DNA replication-uniquely proceeds via nuclear RNR-α translocation, allowing direct binding to ZRANB3. Also see Supplementary Fig. 15c . Indicated nucleotides are capable of converting lower-order RNR-α species into conformationally distinct α 6RD hexamers. Also see Supplementary Figs 22-23 . Only a fraction of α 6RD -likely those that selectively interact with importin-α 1-translocate into the nucleus. IRBIT 45 is a negative regulator of this nuclear translocation. This novel signaling pathway occurs in diverse mammalian cells not exposed to DNA damage inducers. PCNA antagonizes this interaction. The ZRANB3-RNR-α direct interaction in the nucleus provides the molecular basis of the long-elusive, stage-specific tumor-suppressor role of RNR-α .
IRBIT overexpression reduced nuclear RNR-α ( Fig. 5a;  Supplementary Fig. 29a ), providing further evidence that RNR-α translocation occurs under basal conditions, likely because (α 6 RD ) dATP exists endogenously in cells. These data are consistent with IRBIT counteracting RNR-α nuclear translocation by selectively sequestering (α 6 RD ) dATP and analogs in the cytosol. Analysis of cyclin-E levels further verified that elevation in nuclear RNR-α upon IRBIT knockdown was cell-cycle independent ( Supplementary Fig. 31b ). RNR-β levels were unaltered upon IRBIT knockdown ( Supplementary Fig. 30a,d) . Thus, RNR reductase activity, which is upregulated in IRBIT knockdown cells, is not coupled to RNR-α -translocation. The existence of two opposing α 6 RD -conformation-specific regulators of RNR-α -nuclear importimportin (positive) and IRBIT (negative)-explains why nuclear translocation is partial.
IRBIT knockdown alone sufficiently reduces DNA synthesis. Dual-pulse labeling with EdU followed by BrdU showed a reduced DNA-synthesis rate in IRBIT knockdown cells ( Fig. 5b-d ; Supplementary Fig. 31c ). Because IRBIT is a negative regulator of RNR reductase activity, this result underscores that reductase activity is not positively correlated with changes in DNA-synthesis rate, but nuclear RNR-α levels do correlate with suppressed DNA synthesis. Thus, misregulation of RNR-α nucleus:cytosol partitioning can negatively impact DNA synthesis under conditions in which RNR-α is not overexpressed.
Discussion
We delineate three interesting and interconnected findings: (1) ZRANB3 is a positive regulator of DNA synthesis in 'unstressed' cells; (2) the constitutively expressed RNR-α suppresses DNA replication when in the nucleus, which is a new biological function of this ancient enzyme; (3) RNR-α can translocate to the nucleus and inhibit ZRANB3, which in turn affects DNA synthesis. It is pertinent to stress that this study-undertaken in vitro, in normal cells, in cancerous cells, in transformed cell lines, and in primary cell culture-paints a consistent picture of how RNR-α negatively regulates ZRANB3 function, leading to DNA-synthesis retardation (Fig. 6 ).
There remain residual unknowns. We have not fully delineated how ZRANB3 promotes DNA-synthesis and S-phase entry. One recent report agrees that ZRANB3 depletion leads to elevation of G1-phase, although it did not find an effect on DNA-synthesis rate in ZRANB3-deficient cells not exposed to DNA-damage inducers 46 . These observations are likely a manifestation of the complex regulatory networks that exist for ZRANB3 and further indicate that there are additional regulators and compensatory factors of this axis to be discovered.
Although we identified a functional ZRANB3 mutant defective for RNR-α binding and hypomorphic for nuclear RNR-α -promoted DNA-synthesis downregulation, identification of the corresponding sites on RNR-α is limited by intolerance of the human RNR-α protein to most mutations without perturbing its activity, function, or solubility. However, our data involving binding studies between RNR-α (D57N) and ZRANB3 in lysates (no nuclear/cytosol-segregation), and recapitulation of many downstream assays with the engineered NLS-tagged-RNR-α constructs (thereby by-passing hexamer-inducer-treatment), collectively indicate that the RNR-α N-terminal-domain-based dimer interface-obligate for RNR-α trimer-of-dimer ((α 2 ) 3 ) formation 3, 5, 8, 9, 12, 47 -is not necessary for ZRANB3-RNR-α interaction. Structure-based knowledge at the atomic level will ultimately enable novel interventions tapping into this growth-suppressive axis.
Finally, the importance of the ZRANB3-RNR-α interaction in more complex disease models remains to be tested. We have identified many regulators of RNR-α -nuclear translocation and one negative regulator of the RNR-α -ZRANB3 interaction. These variables are critical for predicting how nuclear RNR-α may impact proliferation/transformation in a given cell-type and context. However, we cannot rule out other factors that influence this signaling pathway.
The delegation of RNR-α as a dual regulator of DNA replication cements the privileged position of RNR in mammalian physiology and is elegantly parsimonious in design. RNR-α can assume this linchpin role because it is one of the most sensitive and versatile dNTP-pool sensors. Our single-fiber analysis shows a decrease in average fiber length on the order of magnitude of that reported in IRBIT knockdown cells (25-30%) 45 which we show display elevated nuclear-RNR-α levels. The magnitudes of proliferation suppression are similar to decreases in DNA synthesis measured by fiber staining, fiber combing, and dual-pulse labeling. We also observe changes in cell-cycle distribution upon ZRANB3 knockdown and nuclear RNR-α accumulation. Interestingly, for RNR-α overexpression, S-phase arrest occurs; whereas when ZRANB3 is knocked down, G1-stall dominates even though passage through S-phase is also slowed. This discrepancy is not ideal. However, these differences could reflect that ZRANB3 is multifunctional and that nuclear RNR-α affects some, but not all, ZRANB3 functions. It is also possible that RNR-α overexpression exerts effects other than ZRANB3 knockdown that relax G1-arrest, allowing movement into S-phase. Nevertheless, ZRANB3 knockdown and RNR-α overexpression are epistatic for DNA synthesis suppression, and thus function in the same DNA-synthesis pathway.
The fact that IRBIT knockdown and increased cellular dATP, which result in elevation and decrease of RNR enzymatic activity 3, 45 , respectively, promoted functional translocation lends credence to the nonenzymatic nature of this activity. Because our data indicate that elevated nuclear RNR-α does not affect global dNTP pools, IRBIT binding and nuclear translocation are functionally redundant in terms of global RNR reductase activity. Thus negative regulation of RNR-α translocation by IRBIT likely serves to control RNR-α cytosol/nucleus partitioning. However, dNTP-synthesis regulation and DNA-synthesis inhibition are not equivalent functions. dNTPs present at any given moment can only produce a small fraction of the genome 48 . Thus regulated dNTP production is required to sustain high-fidelity DNA synthesis: lowering dNTP pools promotes ribonucleotide incorporation 49 and affects origin-firing 50 , and hence is not optimal for downregulation of DNA synthesis. Elevated dNTP pools are inherently mutagenic 3 . This imbalance cannot be redressed by modulating RNR reductase activity, so transient DNAsynthesis inhibition is likely more appropriate.
Thus, RNR-α directly influences DNA replication by reducing DNA synthesis upon dNTP-pool imbalances. When dATP levels are elevated, RNR reductase activity is downregulated, rendering RNR-α poised to assume a secondary role. RNR-α nuclear translocation is rapidly reversible. Retrotranslocation occurs on the order of dATP degradation 44 , and thus RNR-α translocation provides a mechanism whereby DNA synthesis can restart once nucleotide levels are rebalanced.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41589-018-0113-5.
Plasmids. Plasmid pCMVTNT-T7-KPNA2 (importin-α 1) (26678), pcDNA3-3Xmyc-Nrf2 (21555) and pcDNA5/FRT/TO-Venus-Flag (40998) were purchased from Addgene. pOG44 Flp-Recombinase Expression Vector was purchased from Thermo Scientific. Empty pcDNA3 plasmid was a gift from B Baird (Cornell University). pfastbac-GST-IRBIT was a gift from A. Arnaoutov (Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD). The plasmids pMIR-His 6 -RNR-α , pMIR-DsRed-IRES-His 6 -RNR-α , and pET28a-His 6 -RNR-α were gifts from J. Stubbe (Massachusetts Institute of Technology). The plasmids SFB-ZRANB3, SFB-ZRANB3-Δ PIP and SFB-ZRANB3(Q519A) were gifts from J. Yuan (Columbia University Medical Center). The plasmids YFP-ZRANB3 and Flag-ZRANB3 were gifts from D. Ahel (Oxford University). The plasmid pet15b-His 5 -PCNA was a gift from Z. Zhang (University of Delaware). The pcDNA3-RNR-α expression plasmids and SFB-ZRANB3 mutant plasmids were constructed as described in Supplementary Table 1 
Validation of antibodies.
Many of the antibodies were themselves used to show knockdown of proteins using multiple shRNAs. The antibody specificities of RNR-α and RNR-β were verified using targeted siRNA knockdowns (see above for sequence information). For instance, the percentage loss of fluorescence staining was quantitated to be 68-72% (three replicates; P < 1 × 10 −15 with respect to the control for each (for cytosol); and < 1 × 10
/1 × 10 −8 (for nucleus)) and 33% for endogenous RNR-α . In addition, for many experiments results were replicated by detecting ectopic expression of an epitope-tagged version (where the gene of interest from both nontransfected and transfected cells can be viewed in the same frame, validating the specificity of the antibody). By this metric, we showed that the data for ectopically overexpressed proteins are consistent with the IF data for the endogenous protein. Anti-Flag/myc/HA were used to detect many ectopic proteins, thereby eliminating doubts about antibody specificity. Within the IF experiment protocols and SI figure legends, we have cautioned the readers for the choice of methanol over formaldehyde fixing method in IF, because many anti-RNR antibodies and various fixing methods gave rise to nonconsistent results between ectopic proteins vs. overexpressed proteins. All of our data were consistent across cell lines from multiple species (human, monkey, mouse) as well as cell types (HeLa, COS-7, HEK293T, K562, Raji, OCI-LY3, etc.) and primary cells from knock-in mice. With nucleus/cytosol fractionation, leakage of more proteins (including RNR-α /RNR-β , etc.) from the nucleus happens over the course of the procedure. We thus consistently used IF as an independent validation for all of the cell-fractionation analysis. Notably, the western blot and IF data for the respective endogenous proteins in native cells we present are consistent with various literature reports from independent labs wherever possible.
Equipment. Plate reader assays were carried out on a Biotek Cytation 3 plate reader. All imaging was carried out on a Zeiss LSM710 or i880 confocal microscope (Cornell Biotechnology Imaging Core Facility), equipped with an Inverted Axio Observer.Z1 microscope with 405, 458, 488, 514, 543, 561, and 633 nm laser lines. Electron microscopy was performed was performed in a JEOL 2010F FEG electron microscope (Canadian Centre for Electron Microscopy; McMaster University). Flow cytometry was carried out on a Beckman Dickinson LSR-II flow cytometer (Cornell Biotechnology Flow Cytometers Core Facility) equipped with 407, 488, 633 nm lasers. Typically, single color analysis was conducted. For twocolor analysis, chromatically orthogonal fluorophores (488, 647 nm) were used without compensation aside from NHEJ assays, where compensation was applied as required. Western blots were all imaged using HRP-conjugated secondary or primary antibodies. Gels were stained using Coomassie brilliant blue. Gel imaging was performed using a ChemiDoc Imager (Bio-Rad).
Sample size n for figures with quantification. n for imaging experiments represents the number of single DNA fibers, single cells, or in a few instances, panels quantified from at least ten fields of view. n for western blot represents the number of lanes on western blots under identical experimental conditions from biologically independent experiments. All imaging data originate from at least three or more independent biological replicates using cells cultured in independent flasks or dishes and at different passage numbers (all kept below no more than 10 passages, and for shRNA lines below 5 passages). All t-tests were two-tailed and unpaired. The total number of degrees of freedom for all the two sample t-test is n1 + n2-2, where n1 and n2 represent sample size n for the two samples. The confidence interval for all the test is 95%.
Cultured cells and generation of MEF cultures from Rrm1
+/D57N mice. Cell lines-HEK293T, Cos-7, HeLa, and K562-were from ATCC. Flp-In T-REx cells were from Invitrogen. All cell lines were validated mycoplasma free using the MycoGuard Mycoplasma PCR detection Kit every three months. Cells were maintained below passage 10, and were thawed from stocks of cell lines that had previously been validated to be mycoplasma free. Most cells were grown in MEM supplemented with 10% FBS, 1X pyruvate and nonessential amino acids and 1X penicillin/streptomycin in a humidified atmosphere at 37 °C with 5% CO 2 . K562 cells were grown in RPMI supplemented with 10% FBS and 1X penicillin/ streptomycin in a humidified atmosphere at 37 °C with 5% CO 2 . All animals used in this study were handled in accordance with federal and institutional guidelines, under a protocol approved by the Cornell University Institutional Animal Care and Use Committee (IACUC). To create Rrm1 D57N knock-in mice, the Rrm1 D57N point mutation was introduced into the endogenous mouse Rrm1 locus by homologous recombination in mouse embryonic stem cells, using a targeting construct that was generated by recombineering and contained a guanine-to-adenine transition in codon 57, in the third exon of mouse Rrm1. (Rrm1 is the gene for mammalian RNR large subunit, RNR-α .) Correctly targeted clones were confirmed by Southern blotting and sequencing, and the Neo cassette used for positive selection was removed by Cre-mediated recombination. A detailed description of the resulting Rrm1 D57N knock-in mouse strain will be published elsewhere. To generate mouse embryonic fibroblast cultures, Rrm1 +/D57N mice on the 129S6 strain background were interbred in timed matings, and embryos were collected and cultured at mid-gestational stages. Genotyping was performed by PCR on DNA from yolk sac tissue. Mouse embryonic fibroblasts were grown on glass bottomed dishes in DMEM supplemented with 10% FBS and 1X penicillin/streptomycin in a humidified atmosphere at 37 °C with 5% CO 2 . Cell stocks were maintained in 10% DMSO in FBS and stored in liquid nitrogen.
Generation of isogenic Flp-In T-REx HEK293 and HeLa cells. For generation of isogenic Flp-In T-REx HEK293 or HeLa cell lines expressing RNR-α -NLS-2XFlag
and DsRed, Flp-In T-REx HEK293 cells were cultured in MEM supplemented with 10% FBS, 1X pyruvate and nonessential amino acids, 100 µ g/ml zeocin and 1X penicillin/streptomycin in a humidified atmosphere at 37 °C with 5% CO 2 . The cells were co-transfected with the POG44 vector encoding the Flp recombinase and pcDNA5/FRT/TO-RNR-α -NLS-2XFlag using Mirus 2020 in 6 well plates. Two days after transfection, the cells were split and passaged into 10 cm dishes, and then after 1.5 d were changed to selective media containing 150 µ g/ml hygromycin B. After 3 weeks, single colonies had formed, and these were ultimately harvested using cloning cylinders. Individual clones were grown in 12-well plates and verified for expression using western blot or imaging. To induce expression, cells were exposed to 100-200 ng/ml tetracycline and incubated for 48 h before treatment with EdU for 45 min, which was followed by fixing.
Generation of knockdown cell lines using lentivirus. HEK293T packaging cells were seeded and grown overnight in antibiotic-free media in 6-well plates. At 80% confluence, each well was transfected with packaging plasmid (pCMV-R8.74psPAX2, 500 ng), envelope plasmid (pCMV-VSV-G, 50 ng) and pLKO vector (500 ng) using TransIT.LT1 as per the manufacturer's protocol. After 18 h media were removed and replaced with 20% serum containing media. After 24 h, media were collected, spun down and passed through a 0.8 micron filter and stored at -80 °C or used directly. Cells in log phase were treated with 1 ml of virus supernatant (from above) in 8 μ g/ml polybrene in a total of 6 ml of media in a 6-well plate. After 24 h, media were removed and replaced with media containing 2 μ g/ml puromycin (which was 100% toxic to all lines used in this study). Cells were cultured until the plate was confluent, and then cells were split and moved to a 10-cm dish in 2 μ g/ml puromycin containing media and grown till confluent again. At this point the line was considered to be 'selected' , and expression of the target gene was analyzed by western blot and compared to shRNA controls. Up to passage 5 was used for these cells and they were typically grown in 1.5 μ g/ml puromycin.
SDS-PAGE and western blot. SDS-PAGE was carried out using polyacrylamide gels (typically 10%) on a Bio-Rad miniprotean II apparatus. Transfer was carried out using a tank apparatus in transfer buffer (Towbin Buffer containing 15% MeOH). Samples were transferred onto PVDF membrane that had been preequilibrated in 100% MeOH for 3 min, and then transfer buffer until required, at 90 V for 1 h, followed by 90 V for 3-4 h in an ice bath with stirring. Blots were blocked in 5-10% fat-free milk (Wegmans) then exposed to primary and secondary antibodies in 1% fat free milk. All blocking/incubation/wash solutions were made in 100 mM Tris pH 7.6, 150 mM NaCl, 0.05% Tween-20. Aside from last wash before visualization that did not contain Tween-20. Mostly blocking was carried out for 1 h at room temperature (25 o C, rt), and the blot was incubated with primary antibody overnight at 4 °C. Secondary antibody incubation was for 40-60 min. When required, HRP was inhibited using sodium azide, or blot was stripped using SDS/BME (55 °C).
Nucleus:cytosol fractionation. Cells were detached using trypsin and washed twice with PBS. The cell pellet was then resuspended in around five pellet volumes of extraction buffer A (20 mM Tris, pH 7.6, 0.1 mM EDTA, 2 mM MgCl 2 , 0.5 mM NaF and 0.5 mM Na 3 VO 4 with recommended amount of Roche protease inhibitor tablet). After incubation for 2 min at rt and for another 10 min on ice, a 10% Nonidet P-40 solution was added to obtain a final Nonidet P-40 concentration of 1%. The cytosolic extract was separated from intact nuclei by centrifugation in a prechilled tabletop centrifuge at 4 °C and 500 × g for 3 min. The top 50% of the supernatant was aspirated and saved as cytosolic extract. The pellet was then washed three times with 10 pellet volumes for extraction buffer A with 1% Nonidet P-40. Each time, the nuclei were pelleted by centrifugation at 4 °C and 500 × g for 3 min. The purified nuclear pellet was resuspended in one pellet volume of extraction buffer B (20 mM HEPES pH 7.9, 400 mM NaCl, 25% vol/vol glycerol, 1 mM EDTA, 0.5 mM NaF, 0.5 mM Na 3 VO 4 and 0.5 mM DTT with the recommended amount of Roche protease inhibitor tablet) and vortexed rigorously. The mixture was freeze-and-thawed three times in liquid nitrogen and incubated on ice for 20 min. After that the soluble nuclear proteins was separated from the insoluble fraction by centrifugation at 4 °C and 20,000 × g for 20 min. Typically, 25 μ g of each lysate was analyzed by western blot. During fractionation experiments, leakage from the nucleus occurs over time, and hence basal nuclear levels are dependent on total sample size, which affects the length of time taken to prepare the samples. Hence basal variations are specific-experiment-invariant, but run-to-run variant. Multiple replicates support the same translocation process in four different cell lines and we thus consistently used immunofluorescence (IF) as an independent validation for all of the cell-fractionation analysis. Absolute variations of one lane from one blot and that in another blot are not affecting the conclusions made.
Imaging analysis. Cells were grown in 35-mm glass-bottom plates to appropriate confluence and treated as described. At the conclusion of the experiment, cells were fixed by addition of 2 ml MeOH (-20 °C) for 20 min (-20 °C). MeOH was removed and PBS was added and stored at 4 °C for days to weeks. NOTE: fixing with MeOH is critical for appropriate visualization of RNR-α . For imaging BrdUtreated cells only: directly before blocking, cells were treated with 1 M HCl at 4 °C for 10 min, then 2 M HCl at rt for 10 min and then warmed to 37 °C for 10 min. Cells were then washed three times with PBS and carried straight on to blocking. When required cells were treated with 2 ml imaging blocking buffer: 3% BSA and 0.2% Triton x-100 in PBS at 37 °C for 1 h. Plates were washed two times with PBS (1 ml), then treated with primary antibody (dilutions: RNR-α (Abcam, ab81085), RNR-β (Abcam, ab57653), IRBIT (Santa Cruz, SC162507), Flag (Fisher Pierce, PA1-985) 1:200; BrdU (Abcam, ab8152), γ -H2AX (Millipore, 05-636) 1:1,000) in antibody incubation buffer: 1% BSA and 0.02% Triton x-100 in PBS, using 120-150 μ l to cover only the glass portion of the plate. Plates were incubated at rt for 2 h. Primary antibody was removed (it could be reused at least 3 times) and plates were washed two times with PBS (1 ml). Then, secondary antibody (120-150 μ l; 1:1,000 dilution in antibody incubation buffer) was added (1 h). Plates were washed one time in PBS containing 1 μ g/ml DAPI, then once with PBS and stored at 4 °C until ready to image. For imaging Raji cells, all steps before fixation were performed on non-adhered cells. Prior to imaging, cells were placed on fibronectin-coated glass backed imaging plates for 10 min, and media was then removed and adhered cells were fixed and analyzed similarly to above.
For imaging of EdU-treated cells, after blocking step, cells were treated with a freshly made mix of 1 mM CuSO 4 (from a 100 mM CuSO 4 stock in water), 10 mM sodium ascorbate in 50 mM HEPES pH 7.6, and 15 μ M Cy5-azide was added directly to cells for 40 min in the dark. Note 1: this mix must be made just before use. Note 2: treating with HCl is NOT required for EdU-treated cells. Then cells were treated with imaging blocking buffer for 10 min and washed twice with PBS; then, primary antibody buffer was applied and subsequent steps were carried out as described above.
Quantification of imaging data. Quantification of nucleus:cytosol partitioning in images was performed using the histogram function in Image-J (NIH). For all instances, at least 40 cells from multiple independent frames were captured. Plotted data show mean ± s.e.m. > 40 cells per point. Most of the magnification settings were 40× water objective with 10× digital zoom. Imaging data shown are mean and s.e.m. and significance was assessed using the t-test. For EdU/BrdU incorporation analyses, data were collected using a 20× oil objective with 10× zoom and calculated using manual picking of cells transfected or nontransfected, or incorporating or not-incorporating BrdU/EdU. These were split into groups of 20-40 cells arbitrarily, and the number of cells positive/negative for BrdU or EdU incorporation, and/or positive or negative for transfection, was calculated. This was repeated > 16 times, and then the means of the total group sets was calculated and compared using the t-test. On average, ~20 groups in total were evaluated. For all other data sets, data were collected using a 40× water objective with an 8× zoom (3% BSA in 50 mM HEPES pH 7.6) at 37 °C for 1 h. Cells were washed once with 50 mM HEPES pH 7.6 then a fresh mix of 1 mM CuSO 4 (from a 100 mM CuSO 4 stock in water), 10 mM sodium ascorbate in 50 mM HEPES pH 7.6 and 15 μ M Cy5-azide was added directly to cells for 40 min (with rotation in the dark). Note: this mix must be made just before use. Cells were centrifuged and washed with blocking buffer for 10 min, then washed once with PBS. 100 μ l primary antibody in primary incubation buffer (1% BSA in PBS) was next added and incubated with the fixed cells for 1-2 h with rotation in dark. After this time, rotation could be moved to 4 °C until needed for a few hours to overnight. Cells were washed once with PBS, then 300 μ l secondary antibody (1:800 dilution, must use a chromatically orthogonal dye such as Alexa-488) was added in primary incubation buffer for 1 h only. Cells were then washed once with primary incubation buffer (500 μ l), and subsequently analyzed by flow cytometry.
Streptavidin pulldown of SFB-tagged ZRANB3 and associated proteins. HEK293T cells were transfected with plasmids encoding SFB-tagged ZRANB3 wild type or mutants and HA-tagged RNR-α . After 36 h, cells were harvested and washed twice with PBS and once with 50 mM HEPES pH 7.6. Cells were resuspended in lysis buffer (50 mM HEPES pH 7.6, 100 mM NaCl, 1% Nonidet P-40, with Roche protease inhibitor tablets) and freeze thawed, and vortexed with glass beads three times. The lysate was spun down (15,000 × g, 10 min at 4 °C) and normalized to 4 mg/ml using the lysis buffer containing 0.5% Nonidet P-40. To this lysate was added 25 μ l streptavidin resin pre-washed and equilibrated with the same lysis buffer. The suspension was incubated for 2 h at 4 °C. The mixture was spun down (900 × g, 5 min), supernatant was removed, and the resin was washed three times with 5 min incubation during each wash in 1 ml of 50 mM HEPES pH 7.6, 100 mM NaCl, 0.1% Nonidet P-40 (wash buffer) at rt. Proteins were eluted using 3 mg/ml biotin in wash buffer at 4 °C for 2 h.
Identification of RNR-α interactor by yeast two-hybrid screening. Y2H screening was performed by Hybrigenics (ULTImate Y2H) (http://www. hybrigenics.com). The RNR-α bait was constructed as a Gal4 N-terminal fusion in pB43, a Y2H vector optimized by Hybrigenics. To generate an expression library, a randomly primed cDNA library from human HeLa cells (RP1) was constructed and inserted into the pP6 vector. Ninety-seven million interactions were analyzed in the screening. After selection on medium lacking histidine, 54 positive clones were chosen and sequenced. Sequences were compared with the latest release of the GeneBank database using BLAST.
Cell cycle analysis using flow cytometry. Cells were grown as described. At the desired time (typically 50% confluence) cells were harvested, pelleted by centrifugation (700 × g) then resuspended in PBS (300 μ l). To this, chilled EtOH (700 μ l), was added dropwise with regular mixing. Cells were maintained at 4 °C until required (they can be left for at least a month in the dark). Cells were pelleted and washed with 1% BSA in PBS two times. Cells were then incubated with 50 μ g/ ml propidium iodide (PI) (300 μ l from a master 1X stock mix) at rt for 30 min with rotating in the dark. To this was then added RNase (30 μ l 10 mg/ml) with continued shaking for 30 min. Samples were stored in the dark at 4 °C until required. Analysis was carried out using FlowJo (tree star) by finding the largest side (SSC-A) and forward (FSC-A) scatter group in DMSO-treated cell population (typically 70% of total samples in control) (See representative data below). This was then analyzed for PI staining (488-2 channel) height and width, or forward scatter width and area, to give single cells in the scatter population (typically > 94% scatter group, irrespective of condition), as shown below. These two gates were applied to all samples within a single experiment, and each cell sample was analyzed further. Percentage G1/S/ G2-M are shown for points within the single cell population. Representative data for histograms are given in Supplementary Figs. 13a, 32-34 , and 30e.
Nonhomologous end joining (NHEJ) reporter assay. NHEJ was measured according to the method developed by Gorbunova and co-workers 56 . Briefly, the NHEJ reporter plasmid contains a GFP sequence interrupted by the Pem1 intron that is itself interrupted by adenovirus exon 2. This plasmid does not code for a functional GFP due to the adenovirus exon (verified by us; data not shown); however, if the adenovirus exon is removed by I-SCE1 digestion (mimicking DSB formation), upon NHEJ this plasmid can form a functional Pem1 intron, and produce functional GFP. Cells undergoing NHEJ are read off as GFP positive relative to a co-transfected DsRed plasmid used as a marker for all transfected cells. Cells at 50-70% confluence in 6-well plates were transfected with a plasmid mix containing linearized reporter plasmid (0.5 µ g; ISCE-1 treated for 8 h, followed by gel extraction), pDsRed2-N1 (0.2 µ g) and test plasmid (2.5 µ g) (i.e., construct encoding RNR-α variant), using 7.5 µ L TransIT-2020 (Mirus) for 36-40 h. After this time, cells were trypsinized, resuspended in 1% FBS in PBS and analyzed by flow cytometry. Compensation was applied based on GFP-only or DsRed-only expressing cells.
Measurement of deoxyribonucleotide levels. dNTP levels were measured according to Sherman and Fyfe method with modifications described in Bianchi et al. 57 . Briefly, HEK293T or HeLa cells, grown on 10 cm 2 culture dish, were harvested, washed once with PBS and extracted with ice-cold 60% methanol and BrdU intensities of individual EdU-positive cells were calculated, averaged and analyzed using the t-test.
Electron microscopy data acquisition and rotational symmetry analysis and maximum-likelihood-based classification approach. Complexes were assembled by mixing recombinant RNR-α (10 µ M) with the respective nucleotide (100 µ M, ClFDP as positive control; 250 µ M for CLADP, CLATP, FLUDP or FLUTP) in assembly buffer (50 mM HEPES (pH 7.6), 15 mM MgCl 2 , and 5 mM DTT), for 2 min at ambient temperature. The sample was then diluted 100-fold in assembly buffer (with or without the presence of respective nucleotide inhibitors, as indicated on the result section and figure legends) immediately before depositing onto an EM grid freshly coated with a continuous layer of amorphous carbon. A glow-discharge treatment of 5 mA for 15 s was applied to the EM grids before they were floated on a 5-µ l drop of the diluted assembly reaction for 2 min. Excess of sample was blotted with filter paper and the grids were stained with 1% uranyl acetate for 1 min. Images were collected on a JEOL 2010F electron microscope operated at 200 kV at 50,000 × magnification with a dose of ~20 electrons per Å 2 . Images were recorded on Kodak SO-163 films and scanned on a Nikon Super COOLSCAN 9000 ED producing images with a pixel size of 1.27 Å per pixel. Images were binned by two before they were used to obtain class averages.
Image processing of the electron micrographs was performed with programs from Xmipp, EMAN and Rotastat software packages.
To formally establish the symmetry of the observed rings (Supplementary Table 1 ), particles from the electron micrographs were selected and extracted, and their rotational symmetry was analyzed using the spectral ratio product and Student's t test as implemented in the Rotastat software 51 . These tests compared the rotational power spectra of particle images containing ring-shaped particles with that of background images of the same size. To calculate the class averages of the oligomers exhibiting three-fold rotational symmetry required to first separated particles exhibiting this symmetry from the rest using self-organizing featured maps. Subsequently, a 2D average was computed from these particles. Averages were obtained both for samples in which the reaction was diluted in buffer containing inhibitor (250 µ M) and for those diluted in the buffer without inhibitors. Conformational variability of the hexamers (α 6 RD ) was analyzed using maximum-likelihood-based classification approaches as implemented in the Xmipp software package [52] [53] [54] .
Immunoprecipitation. HEK293T were grown as described. After 36 h, cells were harvested and washed twice with PBS and once with 50 mM HEPES pH 7.6. Cells were resuspended in lysis buffer (50 mM HEPES pH 7.6, 100 mM NaCl, 1% Nonidet P-40, with Roche protease inhibitors, freeze thawed, and vortexed with glass beads three times. The lysate was spun down (15,000 × g, 10 min at 4 °C) and then normalized to 5 mg/ml with a final concentration of 0.5% Nonidet P-40. To lysate was added 50 μ l settled anti-FLAG M2 resin, and it incubated for 30 min at rt. Resin was pelleted (900 × g, 5 min) then washed three times for 5 min each in 1 ml of 50 mM HEPES pH 7.6, 100 mM NaCl, 0.1% Nonidet P-40 at rt. Proteins were eluted using 3X FLAG peptide in wash buffer at 4 °C for 1 h. For examining polyubiquitinated proteins, proteins were eluted using 2X Laemmli Buffer at 60 °C. For experiments in which cells were treated with ClF or dA, all lysis and wash buffers contained 5 μ M ClF-nucleotide or 100 μ M dATP.
DNA fiber staining analysis. HEK293T cells were incubated with 37 μ M IdU for 30 min, and then media were removed and replaced with media containing 250 μ M CldU for 30 min. Spreading of DNA fibers on frosted glass slides was performed as described 55 . Glass slides were then fixed with AcOH/MeOH (1:3) for 10 min and then fixed in 2.5 M HCl for 80 min followed by three washes in PBS. Slides were incubated for 30 min in blocking buffer (PBS with 5% BSA) in a humidified chamber and then rat anti-BrdU antibody (Abcam, ab6326)/mouse anti-BrdU (BD Biosciences, 347580) in blocking buffer were added; slides were kept in a humidified chamber overnight at 4 °C. After washing with PBS three times, the slides were exposed to goat anti-mouse FITC and donkey-anti rat Alexa 568 in blocking buffer at rt for 1 h. Slides were washed three times in PBS then mounted in vecta shield and stored at − 20 °C. Slides were analyzed on a Zeiss 710 confocal instrument. Only fibers that were being synthesized during the first pulse were considered (both green and red) and only the length of the fibers formed during the second pulse were analyzed.
DNA fiber combing analysis. This protocol was conducted as directed by Genomic vision. Visualization was performed essentially the same way, except anti-ssDNA was omitted and dual color imaging was carried out on a confocal microscope.
EdU analysis using flow cytometry. 30,000 HEK293T cells were plated in a 6-well plate. After 1.5 d, at approximately 30% confluence, cells were transfected with the indicated plasmid and maintained for 36 h. After this time, cells were trypsinized, washed with media, spun down (700 × g), and resuspended in 100 μ l PBS, then fixed (with 900 μ l MeOH at -20 °C and then maintained at 4 °C for at least 20 min to a few weeks). When ready, cells were pelleted by centrifugation (1,500 × g, 5 min), supernatant was aspirated, then cells were resuspended in blocking buffer Phos-tag gel. HeLa cells were treated with ClF (5 μ M, 3 h) . The cells were fractionated, and cytosolic and nuclear fractions were resolved on a 10% Phos-tag gel. For alkaline-phosphatase-treated samples, the lysate was diluted to 2 mg/ml with 1X NEB cutsmart buffer in a total volume of 20 μ l and incubated with 5 units of alkaline phosphatase (AB) for 30 min at rt before loading onto the gels.
Gel recipe for separating layer: 1.7 ml 30% acrylamide-bisacrylamide 37.5:1; 1.25 ml Tris-HCl pH = 8.8 (final concentration 375 mM); 50 μ l 5 mM Phos-tag solution (final concentration 0.05 mM); 50 μ l MnCl 2 (final concentration 0.1 mM); 50 μ l 10% SDS (final concentration 0.1%); 1.88 mL H 2 O; 5 μ l TEMEDA; 25 μ l 10% APS. For western blot, the gel was incubated in 10 mM EDTA (pH = 7.0) for 10 min before soaking in transfer buffer.
Co-immunoprecipitation of endogenous proteins with cross-linkers. HEK293T cells were grown to 30% confluence in 10-cm plates and then transfected with siRNAs (either SiCont or siZRANB3) for 2 d. After this time cells were approximately 80% confluent and were treated with either ClF (5 μ M) or DMSO for 3 h. After this time media were replaced with serum-free media containing EGS (1 mM; DSS was used at the same concentration) with or without ClF (5 μ M). After 1 h, cells were harvested by trypsinization, collected and washed three times in 200 mM Tris (pH 7.5). Cell pellets were resuspended in lysis buffer (200 mM Tris (pH 7.5), 150 mM NaCl, 1% triton, with 2X protease inhibitors) and then lysed by vortexing with glass beads/freeze thawing three times. Lysates were clarified by centrifugation at 18,000 × r.p.m. for 10 min at 4 °C. 500 μ g lysate in 500 μ l volume was then precleared with 75 μ l nonconjugated protein G agarose beads at rt for 2 h. The day before lysis, protein G resin was bound to anti-RNR-α (rabbit) in (50 mM Tris pH 7.6, 150 mM NaCl, 0.2% BSA, 1% Triton) overnight at 4 °C. The resulting beads were rinsed three times in lysis buffer just before pulldown. The washed anti-RNR-α protein G agarose resin (75 μ l) was then added to the precleared lysate (500 μ l) and incubated at 4 °C overnight. Resulting beads were washed 3 times in lysis buffer at rt for 10 min, then bound complexes were eluted by heating in Laemmlli buffer. Samples were analyzed by western blot.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Data availability. All data generated or analyzed during this study are included in this published article and its supplementary information files.
In vitro pulldown assay. All recombinant proteins were buffer exchanged into binding buffer (50 mM HEPES, 100 mM NaCl and 0.5 mM TCEP) using EconoPac 10DG desalting column. During all incubation steps, the samples were subjected to end-over-end rotation at rt. Prior to pulldown, the anti-HA affinity resin was incubated with binding buffer containing 1% BSA over 30 min to block nonspecific sites. After blocking, the resin was incubated with 5 μ M His 6 -HA-HNH&APIM over 30 min. Subsequent to centrifugation and removal of the supernatant, the resin was washed twice with the binding buffer and further incubated with 5 μ M His 6 -RNR-α in buffer containing 1% BSA for 1 h. For competition assay, 20 μ M of recombinant His 5 -PCNA was supplemented into the buffer. After incubation, the resin was spun down and washed as above. Bound proteins were eluted by heating the resin in 2X laemmli buffer, resolved by SDS-PAGE, and stained with Coomassie blue. 
Replication
All attempts at replication were successful with separate cell passages and transfection.
Randomization Prior to beginning an experiment, cells were allocated into wells in the same manner for each sample group. When an experiment was commenced, groups of cells were allocated into treatment groups without pattern or bias. This ensured that each treatment group in an experiment were identical within the inherent variation caused by cell seeding.
Blinding
No human research participants were used and animals were used only to generate fibroblast cultures, so there was no big issue about blinding for group allocation in this study.
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